Search Results
Dr. Bollard Discusses T Cell Resistance to TGF-Beta in Lymphoma
TGFb-resistant NK cells for hematological malignancies
T-Cell Therapies - Catherine Bollard, MD | Pediatric Grand Rounds
Dr. Bollard on the Treatment of EBV-Positive Lymphoma
Improving T-cell therapy with antigen specific T-cells
Professor Malcolm K Brenner - Overview of cell therapy for cancer in 2022 and beyond
KEYNOTE: Catherine Bollard, M.D., MBChB, Children’s National Health System
How immunotherapies are re-shaping the treatment of lymphoma
Cutaneous T-Cell Lymphoma Treatment: The Old and the New - Part 3 of 3
Autologous Tgfβ-Resistant HPV-16/18 E6/E7-Specific T Lymphocytes...for the Treatment of Cancers
Dr. Zain on Ongoing Trials in T-Cell Lymphomas
TGF-BETA AND CANCER IMMUNOTHERAPY: UNDERSTANDING THE ROLE IN TREATMENT
